CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-12-17 | BUSH MICHAEL J CEO | Purchase | +300 | $0.34 | $102 | 297,778 |
| 2010-12-17 | BUSH MICHAEL J CEO | Purchase | +500 | $0.34 | $169 | 298,278 |
| 2010-12-17 | BUSH MICHAEL J CEO | Purchase | +1,900 | $0.34 | $641 | 300,178 |
| 2010-12-17 | BUSH MICHAEL J CEO | Purchase | +300 | $0.34 | $101 | 300,478 |
| 2010-12-17 | Berg Jeffrey Alan Director | Purchase | +500,000 | $0.34 | $170K | 6,385,600 |
| 2010-12-16 | Berg Jeffrey Alan Director | Purchase | +10,000 | $0.35 | $4K | 5,855,600 |
| 2010-12-16 | Berg Jeffrey Alan Director | Purchase | +10,000 | $0.35 | $4K | 5,885,600 |
| 2010-11-29 | George Christopher Allen SVP and CHIEF INFORMATION OFF | Purchase | +600 | $0.35 | $210 | 600 |
| 2010-09-09 | BUSH MICHAEL J CEO | Purchase | +11,800 | $0.37 | $4K | 150,478 |
| 2010-09-08 | BUSH MICHAEL J CEO | Purchase | +20,000 | $0.38 | $8K | 138,678 |
| 2010-08-23 | Lewis Mary Beth Director | Option exercise | +30,000 | $0.18 | $5K | 30,000 |
| 2010-08-23 | Lewis Mary Beth Director | Option exercise · Employee Stock Option (Right to Buy) | −30,000 | 20,000 | ||
| 2010-08-17 | BUSH MICHAEL J CEO | Purchase | +20,000 | $0.41 | $8K | 118,678 |
| 2010-08-01 | Mitgang Steve Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2010-06-09 | BUSH MICHAEL J CEO | Purchase | +600 | $0.48 | $288 | 98,678 |
| 2010-06-07 | George Christopher Allen SVP & Chief Info Officer | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2010-06-03 | Berg Jeffrey Alan Director | Returned to the company · Stock Option (Right to Buy) | +20,000 | 0 | ||
| 2010-06-02 | BUSH MICHAEL J CEO | Purchase | +9,900 | $0.52 | $5K | 97,978 |
| 2010-06-02 | BUSH MICHAEL J CEO | Purchase | +100 | $0.52 | $52 | 98,078 |
| 2010-06-02 | Lewis Mary Beth Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 50,000 |
Page 26 of 33 · 657 trades